Technology ID
TAB-908

Enzymatically-Active RNA-Dependent RNA Polymerase From a Human Norovirus (Calicivirus)

E-Numbers
E-283-2003-0
Lead Inventor
Belliot, Gael (NIAID)
Co-Inventors
Sosnovtsev, Stanislav (NIAID)
Green, Lisbeth Kim (NIAID)
Chang, Kyeong-Ok
Applications
Vaccines­­­
Therapeutics
Research Materials
Diagnostics
Therapeutic Areas
Infectious Disease
Lead IC
NIAID
ICs
NIAID

The noroviruses (formerly known as “Norwalk-like viruses”) are associated with gastroenteritis outbreaks, affecting large numbers of individuals each year. Emerging data are supporting their increasing recognition as important agents of diarrhea-related morbidity and mortality. The frequency with which noroviruses are associated with gastroenteritis as “food and water-borne pathogens” has led to the inclusion of caliciviruses as Category B Bioterrorism Agents/Diseases. Because the noroviruses cannot be propagated by any means in the laboratory, an important strategy in their study is to development of molecular biology-based tools and replication systems. This invention reports the isolation of the first recombinant, enzymatically-active proteinase and RNA dependent RNA polymerase (RdRp) complex for a human norovirus. This enzyme should facilitate studies aimed at developing therapeutic drugs for norovirus disease.

Licensing Contact: